GT Biopharma (GTBP) Current Leases (2019 - 2020)
GT Biopharma (GTBP) has disclosed Current Leases for 2 consecutive years, with $82000.0 as the latest value for Q3 2020.
- On a quarterly basis, Current Leases fell 38.81% to $82000.0 in Q3 2020 year-over-year; TTM through Sep 2020 was $82000.0, a 38.81% decrease, with the full-year FY2019 number at $120000.0, changed N/A from a year prior.
- Current Leases was $82000.0 for Q3 2020 at GT Biopharma, down from $90000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $161000.0 in Q1 2019 to a low of $82000.0 in Q3 2020.